- AstraZeneca to acquire CinCor Pharma in a deal worth $1,8 bn 11 January 2023
- AstraZeneca to acquire Alexion in a $39 bn cash-and-stock deal 23 December 2020
- Sun Pharma licenses AstraZeneca to sell its oncology drugs in China 06 November 2019
- AstraZeneca and Merck in $8.5-billion oncology deal 27 July 2017
- AstraZeneca licenses cancer drug Zoladex to TerSera Therapeutics 21 February 2017
- AstraZeneca to cut 700 positions 09 December 2016
- Pfizer to acquire part of AstraZeneca's antibiotics business 24 August 2016
- AstraZeneca boost oncology portfolio with $4bn Acerta Pharma deal 17 December 2015
- AstraZeneca to buy ZS Pharma for $2.7 bn 06 November 2015
- US FDA approves AstraZeneca's new dosage for heart drug 'Brilinta' 04 September 2015
- Valeant to buy rights to AstraZeneca's psoriasis drug 01 September 2015
- AstraZeneca,Juno partner to study immune therapy drugs 24 April 2015
- New AIIMS, hike in health policy premiums welcome 28 February 2015
- AstraZeneca acquires Actavis's respiratory business for $600 million 06 February 2015
- AstraZeneca strikes three oncology deals 04 November 2014
- Pfizer drops AstarZeneca take over bid 28 May 2014
- AstraZeneca snubs Pfizer's “opportunistic“ bid 13 May 2014
- AstraZeneca to consider Pfizer's $106-bn bid 02 May 2014
- Pfizer weighs $101-bn bid for AstraZeneca 21 April 2014
- AstraZeneca confirms de-listing from Indian bourses 19 March 2014
- AstraZeneca to buy biotech company Spirogen in $440 mn deal 15 October 2013
- AstraZeneca site to emerge as biotech hub 08 May 2013
- AstraZeneca loses appeal on lung cancer drug rights in India 28 November 2012
- AstraZeneca Q1 profit slumps; CEO quits 27 April 2012
- AstraZeneca eliminates 7,300 jobs in major restructuring 03 February 2012
- AstraZeneca to buy China's generic maker Guangdong BeiKang Pharma 08 December 2011
- AstraZeneca to cut 1,150 sales jobs in the US 08 December 2011
- AstraZeneca - Bristol-Myers to present new data on diabetes drug 27 October 2011
- AstraZeneca scrip slumps after buy-back offer 07 July 2010
- AstraZeneca settles UK tax dispute with £505 million payout 24 February 2010
- AstraZeneca India to pay 500 per cent dividend 23 February 2010
- AstraZeneca inks arthritis drug deal with Rigel 16 February 2010
- US FDA approves AstraZeneca's Crestor 09 February 2010
- AstraZeneca reports profit, cuts 8,000 jobs to cut costs 29 January 2010
- Infosys wins multi-million dollar AstraZeneca deal 15 December 2008
- AstraZeneca, Abraxis rethink cancer drug deal 26 November 2008
- AstraZeneca agrees to cut drug prices in UK, stock plummets 20 November 2008
- Global collaboration to develop new anti-obesity compounds 02 February 2007
- AstraZeneca sues Ranbaxy on Nexium patent 22 November 2005
- AstraZeneca to drop Viozan 29 June 2001
- AstraZeneca launches $ 100 million facility in China 30 April 2001
- AstraZeneca to acquire development rights from Cyclacel 17 April 2001
- AstraZeneca sells off speciality chemicals 13 May 1999
